{"DataElement":{"publicId":"2509610","version":"2","preferredName":"Cytogenetics t(15;17)(q22;q12) Result Status","preferredDefinition":"the outcome of a cytogenetic procedure to identify presence of a chromosomal abnormality with translocation of genes 15 and 17 (PML-RARa, typically associated with promyelocytic leukemia).","longName":"CYT_T_15_17_RES_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2509609","version":"1","preferredName":"Cytogenetics t(15;17)(q22;q12) Result","preferredDefinition":"related to the outcome determined for a chromosomal translocation of genes 15 and 17 from tests that detect and study chromosomes and related disease states caused by genetic abnormalities.","longName":"CYTOGEN_T(15;17)_RES","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2320498","version":"1","preferredName":"Cytogenetics","preferredDefinition":"Cytogenetics is the study of chromosomes and the related disease states caused by numerical and structural chromosome abnormalities.","longName":"C16487","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetics","conceptCode":"C16487","definition":"The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-049D-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2509607","version":"1","preferredName":"t(15;17)(q22;q12) Result","preferredDefinition":"No Value Exists:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C27758:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(15;17)(q24;q21)","conceptCode":"C27758","definition":"A chromosomal translocation associated with creation of a fusion between the PML and RARA genes. It is seen in variants of acute promyelocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B4B8739-AFFC-0384-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-18","endDate":null,"createdBy":"PWEST","dateCreated":"2006-08-18","modifiedBy":"ONEDATA","dateModified":"2006-08-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008571","version":"1","preferredName":"Chronic or Associated Diseases and Exposures","preferredDefinition":"chronic diseases, as well as diseases and exposures associated with cancer.","longName":"CHR_O_ASS_DZ_AND_EXP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9B9249B-AB81-2F8D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-25","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B4B8739-B00D-0384-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-18","endDate":null,"createdBy":"PWEST","dateCreated":"2006-08-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"added per Leukemia Committee request to add new CDE for APL studies","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2019208","version":"1","preferredName":"Cytogenetics Result Status","preferredDefinition":"the reported result of a cytogentics procedure to identify gene abnormalities potentially associated with pathologic disease.","longName":"CYTOGEN_RES_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2558962","version":"1","preferredName":"Indeterminate","longName":"2558962","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B35F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A7E798-A053-540E-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"PWEST","dateModified":"2006-08-18","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A7E798-A056-540E-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"PWEST","dateModified":"2006-08-18","deletedIndicator":"No"},{"value":"Not done","valueDescription":"NOT DONE","ValueMeaning":{"publicId":"2559596","version":"1","preferredName":"NOT DONE","longName":"2559596","preferredDefinition":"NOT DONE","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not done","conceptCode":"CL281691","definition":"No value exists.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5D9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A7E798-A059-540E-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"PWEST","dateModified":"2006-08-18","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A7E798-A05C-540E-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"PWEST","dateModified":"2006-08-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184340","version":"1","preferredName":"Status","preferredDefinition":"Status; a condition or state at a particular time.","longName":"Status","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20AD-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Leukemia CDE Disease Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C56AA8D3-FB63-3E44-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-09-07","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-08-21","modifiedBy":"REEVESD","dateModified":"2012-10-12","changeDescription":"ISO complaint; associated only to non-core CDE; modified VD to make more generic for reuse by other CDEs","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811952","version":"1","longName":"Cytogenetics","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811786","version":"1","longName":"APL Prev Untreated","context":"CTEP"},{"publicId":"2811923","version":"1","longName":"APL Relapse/Refract","context":"CTEP"}]},{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"3314494","version":"1","longName":"Labs","context":"ECOG-ACRIN"},{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"}]}],"AlternateNames":[{"name":"CYT_T_15_17_RES_STAT","type":"OID, ACRIN","context":"ECOG-ACRIN"},{"name":"CYT_T_15_17_RES_STAT","type":"Context Short Name","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"Karyotypic t(15:17) transloca","type":"Preferred Question Text","description":"Karyotypic t(15:17) translocation positive?","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"APL positive for t(15:17)","url":null,"context":"CTEP"},{"name":"EAI141","type":"Alternate Question Text","description":"Does the participant have acute promyelocytic leukemia (APL) or evidence of t(15;17)(q22;q21)?","url":null,"context":"ECOG-ACRIN"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F29455F-004D-7EF0-E053-F662850ACC3F","latestVersionIndicator":"Yes","beginDate":"2006-08-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-10-18","modifiedBy":"TAYLORT","dateModified":"2016-10-18","changeDescription":"10/18/16 tt, Version 2 curated due to change in Short Name.           added per request of Leukemia Committee when modifying templates from Leukemia Pathology Committee recommendations","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}